119 related articles for article (PubMed ID: 32253022)
1. Micellar high performance liquid chromatographic method for separation and validation of two anti-hepatitis C- virus drugs in pure form, human plasma and human urine.
Hassan WS; Elmasry MS; Shalaby A; El-Sayed HM; Zidan DW
Ann Pharm Fr; 2020 May; 78(3):217-229. PubMed ID: 32253022
[TBL] [Abstract][Full Text] [Related]
2. Investigation of anti-Hepatitis C virus, sofosbuvir and daclatasvir, in pure form, human plasma and human urine using micellar monolithic HPLC-UV method and application to pharmacokinetic study.
Zidan DW; Hassan WS; Elmasry MS; Shalaby AA
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():73-81. PubMed ID: 29660665
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of six sequential spectrophotometric methods for quantification and separation of ribavirin, sofosbuvir and daclatasvir: An application on Laboratory prepared mixture, pharmaceutical preparations, spiked human urine, spiked human plasma, and dissolution test.
Hassan WS; Elmasry MS; Elsayed HM; Zidan DW
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Sep; 202():159-173. PubMed ID: 29783148
[TBL] [Abstract][Full Text] [Related]
4. Novel spectrophotometric and factor-based multivariate calibration-prediction techniques for determination of two inhibitors of hepatitis C-virus and hepatocellular carcinoma in pure, human urine, and human plasma.
Zidan DW; Hassan WS; ElMasry MS; Shalaby AA
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Apr; 213():288-300. PubMed ID: 30708286
[TBL] [Abstract][Full Text] [Related]
5. Validated spectrophotometric and chromatographic methods for analysis of the recently approved hepatitis C antiviral combination ledipasvir and sofosbuvir.
Baker MM; El-Kafrawy DS; Mahrous MS; Belal TS
Ann Pharm Fr; 2018 Jan; 76(1):16-31. PubMed ID: 28842163
[TBL] [Abstract][Full Text] [Related]
6. UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients.
Notari S; Tempestilli M; Fabbri G; Libertone R; Antinori A; Ammassari A; Agrati C
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():183-190. PubMed ID: 29276983
[TBL] [Abstract][Full Text] [Related]
7. Validated RP-HPLC Method for Simultaneous Determination of Ribavirin, Sofosbuvir and Daclatasvir in Human Plasma: A Treatment Protocol Administered to HCV Patients in Egypt.
Youssef AA; Magdy N; Hussein LA; El-Kosasy AM
J Chromatogr Sci; 2019 Aug; 57(7):636-643. PubMed ID: 31063182
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissolution studies.
Baker MM; Hammad SF; Belal TS
Drug Dev Ind Pharm; 2019 Jul; 45(7):1111-1119. PubMed ID: 30929537
[TBL] [Abstract][Full Text] [Related]
9. Micellar HPLC method for the simultaneous determination of three anticonvulsant drugs in dosage forms and biological fluids. Application to dissolution-rate testing.
Belal F; Ibrahim F; Sheribah ZA; Alaa H
Ann Pharm Fr; 2018 May; 76(3):172-186. PubMed ID: 29576201
[TBL] [Abstract][Full Text] [Related]
10. Feasible TLC-Spectro-Densitometry Technique for Simultaneous Determination of Two Hepatitis C Antiviral Drugs, Sofosbuvir and Simeprevir: Application to Combined Pharmaceutical Dosage Forms and Human Plasma.
Mohammed BS; Derayea SM; Hamad AE
J Chromatogr Sci; 2021 May; 59(6):576-583. PubMed ID: 33822903
[TBL] [Abstract][Full Text] [Related]
11. Green analytical chromatographic assay method for quantitation of cyclobenzaprine in tablets, spiked human urine and in-vitro dissolution test.
Walash MI; El Abass Mohamed SA
Ann Pharm Fr; 2019 Sep; 77(5):418-425. PubMed ID: 31296331
[TBL] [Abstract][Full Text] [Related]
12. Optimization of a sensitive and robust strategy for micellar electrokinetic chromatographic analysis of sofosbuvir in combination with its co-formulated hepatitis C antiviral drugs.
Rageh AH; Abdel-Aal FAM; Pyell U
J Chromatogr A; 2020 Apr; 1616():460795. PubMed ID: 31918849
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous quantitation of two direct acting hepatitis C antivirals (sofosbuvir and daclatasvir) by an HPLC-UV method designated for their pharmacokinetic study in rabbits.
Atia NN; El-Shaboury SR; El-Gizawy SM; Abo-Zeid MN
J Pharm Biomed Anal; 2018 Sep; 158():88-93. PubMed ID: 29864695
[TBL] [Abstract][Full Text] [Related]
14. Efficient HPTLC-dual wavelength spectrodensitometric method for simultaneous determination of sofosbuvir and daclatasvir: Biological and pharmaceutical analysis.
Abo-Zeid MN; El-Gizawy SM; Atia NN; El-Shaboury SR
J Pharm Biomed Anal; 2018 Jul; 156():358-365. PubMed ID: 29753282
[TBL] [Abstract][Full Text] [Related]
15. Micellar HPLC-UV method for the simultaneous determination of levodopa, carbidopa and entacapone in pharmaceuticals and human plasma.
Belal F; Ibrahim F; Sheribah ZA; Alaa H
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():36-45. PubMed ID: 29843067
[TBL] [Abstract][Full Text] [Related]
16. Measurement of ribavirin and evaluation of its stability in human plasma by high-performance liquid chromatography with UV detection.
Loregian A; Scarpa MC; Pagni S; Parisi SG; Palù G
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):358-64. PubMed ID: 17574937
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a rapid method for the simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS.
Shi X; Zhu D; Lou J; Zhu B; Hu AR; Gan D
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():353-7. PubMed ID: 26363369
[TBL] [Abstract][Full Text] [Related]
18. Comparison between core-shell and totally porous particle stationary phases for fast and green LC determination of five hepatitis-C antiviral drugs.
Ibrahim AE; Hashem H; Elhenawee M; Saleh H
J Sep Sci; 2018 Apr; 41(8):1734-1742. PubMed ID: 29297968
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients.
Agnesod D; De Nicolò A; Simiele M; Mohamed Abdi A; Boglione L; Di Perri G; D'Avolio A
J Pharm Biomed Anal; 2014 Mar; 90():119-26. PubMed ID: 24366212
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the chromatographic determination of the most commonly used anti-hepatitis C drug sofosbuvir and its co-administered drugs in human plasma.
Abdel-Tawab MA; Abd El-Moghny MG; El Nashar RM
Biomed Chromatogr; 2022 Jan; 36(1):e5238. PubMed ID: 34469609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
